Pittman BP - Search Results

1

Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.

Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC. Schindler EAD, et al. Among authors: pittman bp. Headache. 2022 Nov;62(10):1383-1394. doi: 10.1111/head.14420. Epub 2022 Nov 23. Headache. 2022. PMID: 36416492 Clinical Trial.

2

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.

Sloshower J, Skosnik PD, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC. Sloshower J, et al. J Psychopharmacol. 2023 Jul;37(7):698-706. doi: 10.1177/02698811231154852. Epub 2023 Mar 20. J Psychopharmacol. 2023. PMID: 36938991 Clinical Trial.

3

Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses.

Schnakenberg Martin AM, Flynn LT, Sefik E, Luddy C, Cortes-Briones J, Skosnik PD, Pittman B, Ranganathan M, D'Souza DC. Schnakenberg Martin AM, et al. Psychopharmacology (Berl). 2023 Jun;240(6):1235-1246. doi: 10.1007/s00213-023-06356-0. Epub 2023 Apr 12. Psychopharmacology (Berl). 2023. PMID: 37045988 Clinical Trial.

4

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.

Skosnik PD, Sloshower J, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC. Skosnik PD, et al. J Psychopharmacol. 2023 Jul;37(7):687-697. doi: 10.1177/02698811231179800. Epub 2023 Jun 30. J Psychopharmacol. 2023. PMID: 37392016 Clinical Trial.

5

Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.

Schindler EAD, Sewell RA, Gottschalk CH, Flynn LT, Zhu Y, Pittman BP, Cozzi NV, D'Souza DC. Schindler EAD, et al. Among authors: pittman bp. J Neurol Sci. 2024 May 15;460:122993. doi: 10.1016/j.jns.2024.122993. Epub 2024 Apr 2. J Neurol Sci. 2024. PMID: 38581739 Clinical Trial.

6

Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.

Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC. Sloshower J, et al. Sci Rep. 2024 Apr 17;14(1):8833. doi: 10.1038/s41598-024-58318-x. Sci Rep. 2024. PMID: 38632313 Free PMC article. Clinical Trial.

7

Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.

De Aquino JP, Meyerovich J, Xie CZ, Ranganathan M, Compton P, Pittman B, Rogan M, Sofuoglu M. De Aquino JP, et al. Addict Biol. 2023 Sep;28(9):e13317. doi: 10.1111/adb.13317. Addict Biol. 2023. PMID: 37644897 Clinical Trial.

8

Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial.

Grilo CM, Lydecker JA, Jastreboff AM, Pittman B, McKee SA. Grilo CM, et al. Obesity (Silver Spring). 2023 Nov;31(11):2762-2773. doi: 10.1002/oby.23898. Epub 2023 Sep 26. Obesity (Silver Spring). 2023. PMID: 37751990 Clinical Trial.

9

The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [¹¹C]UCB-J.

Toyonaga T, Khattar N, Wu Y, Lu Y, Naganawa M, Gallezot JD, Matuskey D, Mecca AP, Pittman B, Dias M, Nabulsi NB, Finnema SJ, Chen MK, Arnsten A, Radhakrishnan R, Skosnik PD, D'Souza DC, Esterlis I, Huang Y, van Dyck CH, Carson RE. Toyonaga T, et al. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1012-1022. doi: 10.1007/s00259-023-06487-8. Epub 2023 Nov 13. Eur J Nucl Med Mol Imaging. 2024. PMID: 37955791

10

Brief report: The influence of childhood trauma on the effects of delta-9-tetrahydrocannabinol in persons with opioid use disorder.

Rogan M, Nunes JC, Xie CZ, Sofuoglu M, Pittman B, De Aquino JP. Rogan M, et al. Am J Addict. 2024 May;33(3):343-346. doi: 10.1111/ajad.13504. Epub 2023 Dec 7. Am J Addict. 2024. PMID: 38059660 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page